Does DASATINIB Cause Malignant neoplasm progression? 613 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 613 reports of Malignant neoplasm progression have been filed in association with DASATINIB (dasatinib). This represents 2.0% of all adverse event reports for DASATINIB.
613
Reports of Malignant neoplasm progression with DASATINIB
2.0%
of all DASATINIB reports
203
Deaths
126
Hospitalizations
How Dangerous Is Malignant neoplasm progression From DASATINIB?
Of the 613 reports, 203 (33.1%) resulted in death, 126 (20.6%) required hospitalization, and 29 (4.7%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DASATINIB. However, 613 reports have been filed with the FAERS database.
What Other Side Effects Does DASATINIB Cause?
Pleural effusion (2,424)
Fatigue (2,173)
Death (1,741)
Nausea (1,740)
Diarrhoea (1,728)
Headache (1,625)
Adverse event (1,382)
Rash (1,300)
Drug ineffective (1,271)
Hospitalisation (1,181)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which DASATINIB Alternatives Have Lower Malignant neoplasm progression Risk?
DASATINIB vs DATOPOTAMAB DERUXTECAN-DLNK
DASATINIB vs DAUNORUBICIN
DASATINIB vs DAXIBOTULINUMTOXIN A-LANM
DASATINIB vs DAYTRANA
DASATINIB vs DECITABINE